Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (181-190 of 750) with videos related to

Pageof 75
Sort By:
Journal of Clinical Gastroenterology|March 10, 2025
Disparities in Health Care in Patients With Chronic Liver DiseaseMaryam Zafer, Ryan Tang, Maria E Martinez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 5, 2023
Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysisMohammad Zamani, Shaghayegh Alizadeh-Tabari, Puja Chitkara, et al.
Hepatology (Baltimore, Md.)|May 9, 2024
Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver diseaseXiaolong Qi, Jie Li, Cyrielle Caussy, et al.
Hepatology (Baltimore, Md.)|August 13, 2017
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseChris Estes, Homie Razavi, Rohit Loomba, et al.
Gut|May 24, 2015
Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective studyAmir Zarrinpar, Shakti Gupta, Mano R Maurya, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2021
Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity - authors' replyAnne Flint, Grit Andersen, Paul Hockings, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2023
Clinical Trial Landscape in NASHStephen A Harrison, Rohit Loomba, Julie Dubourg, et al.
Hepatology (Baltimore, Md.)|July 21, 2015
Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysisSiddharth Singh, Rohan Khera, Alina M Allen, et al.
Therapeutic Advances in Gastroenterology|May 5, 2022
Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver diseaseVeeral Ajmera, Khang Nguyen, Nobuharu Tamaki, et al.
Gastroenterology|April 26, 2025
PNPLA3 Inhibition and Cardiometabolic Risk: Reassessing Dyslipidemia and ASCVD ConcernsShicheng Guo, Eric Garcia-Medel, Thomas Schluep, et al.
Pageof 75

Showing results (181-190 of 750) with videos related to

Sort By:
Pageof 75
Journal of Clinical Gastroenterology|March 10, 2025
Disparities in Health Care in Patients With Chronic Liver DiseaseMaryam Zafer, Ryan Tang, Maria E Martinez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 5, 2023
Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysisMohammad Zamani, Shaghayegh Alizadeh-Tabari, Puja Chitkara, et al.
Hepatology (Baltimore, Md.)|May 9, 2024
Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver diseaseXiaolong Qi, Jie Li, Cyrielle Caussy, et al.
Hepatology (Baltimore, Md.)|August 13, 2017
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseChris Estes, Homie Razavi, Rohit Loomba, et al.
Gut|May 24, 2015
Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective studyAmir Zarrinpar, Shakti Gupta, Mano R Maurya, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2021
Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity - authors' replyAnne Flint, Grit Andersen, Paul Hockings, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2023
Clinical Trial Landscape in NASHStephen A Harrison, Rohit Loomba, Julie Dubourg, et al.
Hepatology (Baltimore, Md.)|July 21, 2015
Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysisSiddharth Singh, Rohan Khera, Alina M Allen, et al.
Therapeutic Advances in Gastroenterology|May 5, 2022
Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver diseaseVeeral Ajmera, Khang Nguyen, Nobuharu Tamaki, et al.
Gastroenterology|April 26, 2025
PNPLA3 Inhibition and Cardiometabolic Risk: Reassessing Dyslipidemia and ASCVD ConcernsShicheng Guo, Eric Garcia-Medel, Thomas Schluep, et al.
Pageof 75